MIRA
INFORM REPORT
|
Report Date : |
09.05.2014 |
IDENTIFICATION DETAILS
|
Name : |
KUSUM HEALTHCARE PRIVATE LIMITED (w.e.f. 22.12.2004) |
|
|
|
|
Formerly Known
As : |
K. B. FINVEST AND REALESTATES PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
D-158 A, Okhla Industrial Area, Phase- I, New Delhi – 110020 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2013 |
|
|
|
|
Date of
Incorporation : |
12.03.1997 |
|
|
|
|
Com. Reg. No.: |
55-085780 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.79.905 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U65929DL1997PTC085780 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
DELK0745C |
|
|
|
|
PAN No.: [Permanent Account No.] |
AABCK7043B |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer of Pharmaceuticals Products. |
|
|
|
|
No. of Employees
: |
500 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (53) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 6217000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a successor of proprietary concern established in 1977. Then in 2001, the constitution was changed to partnership firm and
later in December 2004, the firm was incorporated into “Kusum Healthcare
Private Limited”. It is a well established and reputed company having satisfactory track
record. The company possesses a favourable financial profile marked by
adequate networth position. The company has seen an improvement in its sales volume as well as net
profitability along with healthy profit margin during 2013. Trade relations are fair. Business is active. Payment terms are
reported as regular. In view of established track record of the promoters, the subject can
be considered for business dealings at usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2014
|
Country Name |
Previous Rating (31.12.2013) |
Current Rating (31.03.2014) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
US investment bank
Goldman Sachs has upgraded its outlook on Indian markets as it expects
positive impact of the election cycle.
India’s economy may grow
4.7 % in the current financial year, lower than the official estimate of 4.9 %,
Fitch Rating said. The global rating agency expects the economy to pick up in
the next two financial years.
Global ratings
agency Standard & Poor said increasing focus by India Inc on lowering debt
is likely to improve their credit profiles.
Singapore (1.1
million Indian tourists in 2012), Thailand (one million), the United Arab
Emirates ().98 million) and Malaysia ().82 million) emerged as the preferred
holidays hotspots for Indians. The total figure is expected to increase to 1.93
million by 2017, according to the latest Eurmonitor international report.
There is a $29.34 bn
outward foreign direct investment by domestic companies between April and
January of 2013/14 which has seen some signs of recovery according to a Care
Ratings report.
There are 264 number
of new companies being set up every day on average during 2014. Most of them
are registered in Mumbai. India had 1.38 million registered companies at the
end of January, 2014.
Twitter like
messaging service Weibo Corporation has filed to raise $ 500 million via a US
initial public offering. Alibaba, which owns a stake in Weibo is expected to
raise about $ 15 billion New York this year in the highest profile Internet IPO
since Facebook’s in 2012.
Bharti Airtel has
raised Rs.2,453.2 crore (350 million Swiss Francs) by selling six-year bonds at
a coupon rate of three per cent and maturing in 2020. This is the largest ever
bond offering by an Indian company in Swiss Francs. Bharat Petroleum
Corporation raised 175 million Swiss Francs by selling five year bonds at 2.98
% coupon rate in February.
Indian Oil
Corporation plans to invest Rs 7650 crore in setting up a petrochemical complex
at its almost complete Paradip refinery in Odhisha in three to four years. The
company board is set to consider the setting up of a 700000 tonne per annum
polypropylene plant at an estimated cost at Rs.3150 crore.
Global chief
information officers at gathering in Bangalore in April to meet Indian startups
at an event called Tech50 Watchout for Little Eye Labs-Facebook type deals in
the making.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
ICRA |
|
Rating |
FUND BASED LIMIT : ICRA BBB |
|
Rating Explanation |
Having moderate degree of safety regarding
timely servicing of financial obligation it carry moderate credit risk. |
|
Date |
September 2013 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
INFORMATION PARTED BY (GENERAL DETAILS)
|
Name : |
Mr. S K Shetty |
|
Designation : |
Account Manager |
|
Contact No.: |
91-1493-516560 |
LOCATIONS
|
Registered Office : |
D-158 A, Okhla Industrial Area, Phase- I, New Delhi – 110020, India |
|
Tel. No.: |
91-11-40527575/ 41005147 |
|
Fax No.: |
91-11-23550714/ 40527575 |
|
E-Mail : |
deepika.cs@kusumhealthcare.com |
|
Website : |
|
|
|
|
|
Corporate Office : |
2E/22, Jhanddewalan Extension, New Delhi – 110055, India |
|
Tel. No.: |
91-11-23678130/31 |
|
Fax No.: |
91-11-23550714 |
|
|
|
|
Factory : |
Plot No. SP 289 (A), RIICO Industrial Area, Chopanki, Bhiwadi, Alwar
(District), Rajasthan, India |
|
Tel. No.: |
91-1493-516560/61 |
|
Fax No.: |
91-1493-516562 |
|
|
|
|
Branch Office: |
Located at ·
Ukraine ·
Moldova ·
Kazakhstan ·
Uzbekistan |
DIRECTORS
As on: 28.09.2013
|
Name : |
Mr. Badri Prasad Gupta |
|
Designation : |
Director |
|
Address : |
BU-102, Pitam Pura, Delhi - 110034, India |
|
Date of Birth/Age : |
17.10.1938 |
|
Date of Appointment : |
29.12.2004 |
|
PAN No.: |
AAWPG7278E |
|
DIN No.: |
00837192 |
|
|
|
|
Name : |
Mr. Sanjeev Gupta |
|
Designation : |
Managing Director |
|
Address : |
B-4/117, Safdarjung Enclave, Delhi-110029, India |
|
Date of Birth/Age : |
08.10.1967 |
|
Date of Appointment : |
12.03.1997 |
|
PAN No.: |
ABLPG4307Q |
|
DIN No.: |
00837248 |
|
|
|
|
Name : |
Mr. Pramod Madhav Sapre |
|
Designation : |
Director |
|
Address : |
401, Vaishali Apartment, 15/21, Janki Kutir, Juhu, Mumbai – 400049,
Maharashtra, India |
|
Date of Birth/Age : |
08.07.1938 |
|
Date of Appointment : |
11.11.2011 |
|
DIN No.: |
01972457 |
KEY EXECUTIVES
|
Name : |
Mr. S K Shetty |
|
Designation : |
Account Manager |
|
|
|
|
Name : |
Mr. Swapnil Gupta |
|
Designation : |
Secretary |
|
Address : |
H. No. 115, Mashiak Ganj, Lucknow – 226018, Uttar Pradesh, India |
|
Date of Birth/Age : |
25.10.1984 |
|
Experience : |
22.04.2013 |
|
PAN No.: |
BAHPG9408A |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on: 28.09.2012
|
Names of Shareholders |
|
No. of Shares |
|
Sanjeev Gupta |
|
5718120 |
|
Kusum Rani Gupta |
|
469040 |
|
Badri Prasad Gupta |
|
1702340 |
|
Seema Gupta |
|
1000 |
|
Nirupma Gupta |
|
100000 |
|
|
|
|
|
Total |
|
7990500 |
Equity Share Break up (Percentage of Total Equity)
As on: 28.09.2012
|
Category |
|
Percentage |
|
Directors or relatives of directors |
|
100.00 |
|
Total
|
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Pharmaceuticals Products. |
|
|
|
|
Exports : |
|
|
Products : |
Pharmaceuticals Products |
|
Countries : |
Ukraine |
|
|
|
|
Imports : |
|
|
Products : |
Raw Materials |
|
Countries : |
Singapore |
GENERAL INFORMATION
|
No. of Employees : |
500 (Approximately) |
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
Bankers : |
·
Oriental Bank of Commerce, Delhi, India ·
Axis Bank Limited ·
Central Bank of India ·
Karnataka Bank |
|||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
Facilities : |
(Rs.
In Millions)
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
ASPN and company Chartered Accountants |
|
Address : |
3927/28, Padam Singh Road, Karol Bagh, New Delhi-110005, India |
|
PAN No.: |
AACFK3713C |
|
|
|
|
Enterprises which are
owned, or have significant influence of or are partners with Key management
personnel and their relatives : |
· Glad Pharma Limited ·
Kusum Pharma |
CAPITAL STRUCTURE
As
on: 31.03.2013
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
10000000 |
Equity Shares |
Rs.10/- each |
Rs.100.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
7990500 |
Equity Shares |
Rs.10/- each |
Rs.79.905 Millions
|
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES
OF FUNDS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
79.905 |
79.905 |
79.905 |
|
(b) Reserves & Surplus |
1474.356 |
1192.093 |
980.014 |
|
(c) Money received against
share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
1554.261 |
1271.998 |
1059.919 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
2.858 |
6.208 |
|
(b) Deferred tax liabilities
(Net) |
3.401 |
7.329 |
7.734 |
|
(c) Other long term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term provisions |
6.018 |
4.941 |
3.723 |
|
Total
Non-current Liabilities (3) |
9.419 |
15.128 |
17.665 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
0.548 |
35.905 |
41.828 |
|
(b) Trade payables |
112.195 |
75.341 |
35.084 |
|
(c) Other current liabilities |
17.220 |
25.177 |
88.828 |
|
(d) Short-term provisions |
22.079 |
22.149 |
50.736 |
|
Total
Current Liabilities (4) |
152.042 |
158.572 |
216.476 |
|
|
|
|
|
|
TOTAL |
1715.722 |
1445.698 |
1294.060 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
258.994 |
235.581 |
240.331 |
|
(ii) Intangible Assets |
9.901 |
7.476 |
6.797 |
|
(iii) Capital work-in-progress |
0.000 |
10.413 |
0.000 |
|
(iv) Intangible assets under
development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.000 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
42.198 |
27.609 |
2.595 |
|
(e) Other Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total
Non-Current Assets |
311.093 |
281.079 |
249.723 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
0.000 |
0.000 |
0.000 |
|
(b) Inventories |
91.950 |
65.521 |
38.264 |
|
(c) Trade receivables |
1195.793 |
970.647 |
855.343 |
|
(d) Cash and cash equivalents |
38.723 |
9.106 |
5.570 |
|
(e) Short-term loans and
advances |
78.163 |
118.239 |
136.075 |
|
(f) Other current assets |
0.000 |
1.106 |
9.085 |
|
Total
Current Assets |
1404.629 |
1164.619 |
1044.337 |
|
|
|
|
|
|
TOTAL |
1715.722 |
1445.698 |
1294.060 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
|
|
SALES |
|
|
|
|
|
|
|
Gross Sales |
1414.209 |
1050.024 |
1199.543 |
|
|
|
Other Income |
NA |
NA |
NA |
|
|
|
TOTAL |
NA |
NA |
NA |
|
|
|
|
|
|
|
|
|
EXPENSES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Administrative Expenses |
|
|
|
|
|
|
Advertising Expenses |
|
|
|
|
|
|
TOTAL |
NA |
NA |
NA |
|
|
|
|
|
|
|
|
|
PRIOR
PERIOD ITEMS |
0.000 |
0.000 |
0.024 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
443.238 |
304.702 |
424.712 |
|
|
|
|
|
|
|
|
|
|
TAX |
144.148 |
108.400 |
13.576 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
|
299.090 |
196.302 |
411.136 |
|
|
|
|
|
|
|
|
|
|
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
1192.093 |
980.014 |
568.878 |
|
|
|
|
|
|
|
|
|
|
APPROPRIATIONS |
|
|
|
|
|
|
|
Transfer to General Reserve |
22.660 |
0.000 |
0.000 |
|
|
|
Dividend |
14.383 |
0.000 |
0.000 |
|
|
|
Tax on Dividend |
2.444 |
0.000 |
0.000 |
|
|
BALANCE CARRIED
TO THE B/S |
1451.696 |
1192.093 |
980.014 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
37.43 |
24.57 |
51.45 |
|
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info
Agents |
Available in Report
(Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
Yes |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact person |
Yes |
|
11] |
Turnover of firm for last three years |
Yes |
|
12] |
Profitability for last three years |
Yes |
|
13] |
Reasons for variation <> 20% |
-- |
|
14] |
Estimation for coming financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details (if applicable) |
Yes |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm / promoter involved in |
-- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking account |
-- |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if applicable |
Yes |
|
29] |
Last accounts filed at ROC |
Yes |
|
30] |
Major Shareholders, if available |
Yes |
|
31] |
Date of Birth of Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of Proprietor/Partner/Director, if available |
Yes |
|
33] |
Voter ID No of Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating, if available |
No |
UNSECURED LOAN
(Rs.
In Millions)
|
Particular |
As on 31.03.2013 |
As on 31.03.2012 |
|
SHORT-TERM
BORROWINGS |
|
|
|
Deposits from directors |
0.548 |
0.000 |
|
|
|
|
|
Total |
0.548 |
0.000 |
NOTE:
The registered office address of the company has been shifted from “21/4, Bhagat Singh Marg, New Delhi – 110001, Delhi, India” to the present address w.e.f. 18.05.2012.
PERFORMANCE AND OPERATIONS
The Company’s revenue from operations during the financial year 2012-13 amounted to Rs. 1410.000 Millions against Rs. 1050.000 Millions in the previous year recording a growth of more than 35percent. This was primarily due to improved realizations, changes in the product mix and induction of new products. As a result, profit after tax increased by more than 53 percent to 30 Millions from Rs. 200.000 Millions in the previous financial year. Another critical focus of this programme is to improve cost effectiveness across products while upholding the highest standards of regulatory, quality and safety requirements. Kusum Healthcare strives to maintain world-class quality for its products and services across all markets. The reserves of the Company have increased from Rs. 1190.000 Millions to Rs. 1470.000 Millions.
Company export wide variety of pharmaceutical products to Common wealth of Independent State (CIS) Countries like Ukraine, Kazakhstan, Uzbekistan, Tajikistan, Moldova and ASEAN countries like Philippines and Vietnam and continuously explores the business opportunities with other countries.
FUTURE PROSPECTS AND
OUTLOOK
The company focus will be to channelise the company’s resources in increasing sales force effectiveness and hence productivity. The contribution from exports to total revenues is more than 98% and is further expected to grow over the years. Additionally, Company will continue working with existing alliances to capture untapped growth opportunities.
The year ahead holds a new promise as the company plans to strengthen its efforts to launch new global products and provide high quality scientific support - all these with a core focus on patient comes first approach. Key economic indicators, overall confidence in economy and increase in government expenditure on health are expected to have positive impact on healthcare industry. The growing network of their company is providing us strong client base for their future expansion to capture more markets to increase Company’s market share and expand in new geographical areas. Considering the business growth, Company has plan for expansion and renovation of existing manufacturing facilities at Bhiwadi location.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l Anti-Money
Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws, regulations
or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.59.99 |
|
|
1 |
Rs.101.75 |
|
Euro |
1 |
Rs.83.48 |
INFORMATION DETAILS
|
Information
Gathered by : |
PDT |
|
|
|
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
VRN |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely
sound financial base with the strongest capability for timely payment of
interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate
working capital. No caution needed for credit transaction. It has above
average (strong) capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial &
operational base are regarded healthy. General unfavourable factors will not
cause fatal effect. Satisfactory capability for payment of interest and principal
sums |
Fairly
Large |
|
41-55 |
Ba |
Overall operation is
considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome
financial difficulties seems comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are
apparent. Repayment of interest and principal sums in default or expected to
be in default upon maturity |
Limited
with full security |
|
<10 |
C |
Absolute credit risk
exists. Caution needed to be exercised |
Credit
not recommended |
|
-- |
NB |
New
Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.